Wojcicki's controversial bid to reclaim 23andMe

Comments
Loading...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Morning. Today, we talk about the likely confirmation of FDA nominee Marty Makary, go in-depth on NIH nominee Jay Bhattacharya, and see how much 23andMe CEO Anne Wojcicki is willing to pay for her own company. 

Read the rest…

Market News and Data brought to you by Benzinga APIs